Company Overview and News
After a decade-long period of unusually low interest rates, a heated up economy and full labor situation are forcing the Fed to once again tighten monetary policy. The result? The era of low interest rates is over. We are now heading back to era of normal interest rates. But there are still stocks to buy as interest rates rise.
WFCNP XOM CAT BAC KSS AEP INTC WFC DUKH C DUK M TGT BP T JPM VZ DE
On Thursday, Robert W. Baird analyst Mircea Dobre upgraded Caterpillar (NYSE:CAT) to an “outperform,” and simultaneously upped his price target on CAT stock to $191, roughly 25% above the stock’s current price.
SNHY CAT MTW CMI DE
2018-09-20 investorplace - 3
Trying to forecast the market — and the world — a decade or two out is no easy task. That makes it difficult to choose long-term stocks to pass along to coming generations. When you’re looking for stocks to invest in for your children or grandchildren, you’re essentially looking for stocks to hold forever. So how do you go about finding such long-term stocks?
JD MCHI NFLX NVDA MDT SHLD BAC AMZN JPM IQ MKC 0700 DG NTES GM INTC DE
2018-09-19 investorplace - 2
U.S. equities are moving higher on Tuesday amid a “sell the rumor, buy the news” dynamic following a tepid response by China to President Trump’s imposition of fresh tariffs on $200 billion worth of Chinese imports on Monday night. An additional 10% tariff will go into effect later this month, which will be increased to 25% in January.
JD BABA CAT BA BIDU DE
Just when you thought summer was winding down, I am writing this in blistering heat out there - as it has just about touched 90 degrees here in Northeast Ohio. Last month, I said it was raining dividends, well this month - we are scorching dividends baby! We are now EIGHT months down with FOUR monstrous months left to kick butt. I have been spending even more time to see where things are looking, financially, and let's just say it'll be a grind through the end of the year.
PG CAT HCP HRL KMI CZNC CM SBUX WRK KMR DAL KMRFZ CVB DE
Industrial stocks as a sector of the S&P 500 have had a tough going year-to-date, yet the price action over the past month or is beginning to show more constructive signs. Many of the large names in the sector such as Deere (NYSE:DE) look similar on the charts as one would expect. DE stock has given the bulls four bullish reversals since late April, and it increasingly looks likely a push higher is in the cards for this name.
2018-08-30 investorplace - 1
Agriculture stocks often find themselves ignored by most stock market investors. They lack the sex appeal of tech or the boom cycles of energy. However, none of us can live without food or the clothing that this sector brings. Also, because farmland serves as a vast American resource, U.S. agriculture goes a long way toward feeding much of the world. In fact, the ag sector finds itself caught in the middle of America’s recent trade war with China.
ICL YUM ACBFF CGC WMT WEN ACB KR IBA WEED TSN MCD DE SMG
Legally or illegally, companies have for centuries copied the intellectual property of their competitors and encroached on their market share. One has only to think back to the commercial espionage of Francis Cabot Lowell, who in 1810-11, while strolling through dozens of British cotton mills, memorized critical details of mechanized textile manufacturing. Using this information, his Boston Manufacturing Company and eventually mills throughout New England took the growing American mass market away from British textile exporters.
PG NVS DE 0550
Chicago, IL – August 20, 2018 – Zacks Equity Research highlights iRobot Corporation (IRBT - Free Report) as the Bull of the Day, Autohome (ATHM - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Deere & Company (DE - Free Report) and Caterpillar (CAT - Free Report) .
DLTR STZ.B IP ATHM CAT IRBT INPAP URI HEAR STZ DE
2018-08-20 247wallst - 1
Stocks were indicated to open marginally higher on Monday, but futures were not indicating any solid directional open. Earnings season is now close to 90% of the way to its end, and over 70% of the companies exceeded expectations. Still, the stock market volatility in 2018 has created less rewarding trades by buying the dips than had been so reliable in prior years. Many investors also are trying to decide how they want their investments positioned ahead of the midterm elections and with international trade concerns.
STZ.B ACHV CARB BHGE STZ CGC BHI TWMJF NKE AMAT WEED BE TRI BRY MS DE CRMT
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to DE / Deere & Co. on message board site Silicon Investor.
as of ET